Who We Are
Who We Are
Since our inception, we have been committed to identifying and maximizing opportunities to develop and commercialize first-in-class, plant-based prescription medicines.
From Tree to Bottle
We are focused on leveraging our broad intellectual property portfolio, our robust and far-reaching pipeline, and our extensive botanical library to develop breakthrough remedies to serve the unmet medical needs of people around the globe.
From Tree to Bottle
We are focused on leveraging our broad intellectual property portfolio, our robust and far-reaching pipeline, and our extensive botanical library to develop breakthrough remedies to serve the unmet medical needs of people around the globe.
The Jaguar Health Family of Companies
Jaguar Health’s organizational framework is designed to enable our product pipeline to reach the world’s interconnected marketplace, allowing for development and commercialization opportunities worldwide.
Jaguar Health is a commercial-stage pharmaceutical company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, and bowel incontinence.
Jaguar family company Napo Pharmaceuticals focuses on developing and commercializing human prescription pharmaceuticals for essential supportive care and management of neglected gastrointestinal symptoms across multiple complicated disease states.
Jaguar family company Napo Therapeutics is an Italian corporation established by Jaguar in Milan, Italy, in 2021, focused on expanding crofelemer access in Europe and specifically for orphan and/or rare diseases.
Under the trade name Jaguar Animal Health, we focus on developing and commercializing first-in-class gastrointestinal products for companion and production animals.
Magdalena Biosciences, a joint venture formed by Jaguar and Filament Health Corp. that emerged from Jaguar’s Entheogen Therapeutics Initiative (ETI), is focused on developing novel prescription medicines derived from plants for mental health indications.
Our Social Responsibility
At Jaguar Health, we prioritize our impact on environmental and social issues. Our focus includes sustainability, community benefit sharing, and recognizing and honoring the wisdom and expertise of the Indigenous healers who first discovered the medicinal properties of specific plants.
Our Social Responsibility
At Jaguar Health, we prioritize our impact on environmental and social issues. Our focus includes sustainability, community benefit sharing, and recognizing and honoring the wisdom and expertise of the Indigenous healers who first discovered the medicinal properties of specific plants.
